Group 1: Stock Market Performance - The US stock market indices showed mixed performance, with the Dow Jones up 0.05%, Nasdaq up 0.31%, and S&P 500 up 0.18% as of September 22 [1] - Tesla's stock rose nearly 3.6% after several institutions raised their target price, with Baird upgrading its rating to "outperform" and predicting a price of $3000 by 2035 [1] - Alibaba's stock increased by nearly 1%, supported by a Citi analyst report highlighting a new in-store group buying promotion coinciding with the travel peak season [1] - Apple's stock surged over 3%, reaching an 8-month high, with Wedbush Securities setting the highest target price on Wall Street at $310 [1] - Baidu's stock saw a rise of over 4% after the launch of its new visual understanding model, Qianfan-VL, which is aimed at enterprise-level multimodal applications [1] Group 2: Mergers and Acquisitions - Metsera, a developer of anti-obesity drugs, saw its stock rise over 60% amid reports that Pfizer is nearing a deal to acquire the company for up to $7.3 billion [3] - Pfizer plans to purchase Metsera at $47.50 per share in cash, with potential additional payments based on performance milestones [3] Group 3: Economic Indicators and Market Sentiment - The Federal Reserve's recent interest rate cut of 25 basis points has led to increased expectations of further cuts, which has been a major driver for the US stock market reaching new highs [5][6] - Concerns are rising regarding the US long-term treasury market and potential budget battles in Congress, which could impact market confidence [5][6] - Upcoming economic data releases, including core PCE and non-farm payroll reports, are expected to influence market sentiment, with predictions leaning towards weaker outcomes [6]